Drug makers call for reassessment of new drugs

Published: 2008-05-16 06:57:00

Updated: 2008-05-16 06:57:00

Representatives from Korea's two business lobby groups - the Korea Pharmaceutical Manufacturers Association and the Korea research based Pharmaceutical Industry Association held a workshop to review the government's reassessment of new antihyperlipidemic agents in terms of cost effectiveness.

The Health Insurance Review Agency said that health insurance prices of Crestor (rosuvastatin) and ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.